PubPeer
The online Journal club
login
create account
Home
Publications
Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs
New England Journal of Medicine (2015) -
Comments
pubmed: 26444323 doi: 10.1056/nejmp1508120 issn: 1533-4406 issn: 0028-4793
Brendan M. Everett, Robert J. Smith, William R. Hiatt
Go to article
Go to preprint
Massachusetts Medical Society
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})